{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:58:20Z","timestamp":1768568300216,"version":"3.49.0"},"posted":{"date-parts":[[2024,9,1]]},"group-title":"Health Informatics","reference-count":47,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Guidelines recommend pharmacological venous thromboembolism (VTE) prophylaxis only for high-risk patients, but the probability of VTE considered \u201chigh-risk\u201d is not specified. Our objective was to define an appropriate probability threshold (or range) for VTE risk stratification and corresponding prophylaxis in medical inpatients.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients were adults admitted to any of 10 Cleveland Clinic Health System hospitals between December 2020 and August 2021 (N = 41,036). Hospital medicine physicians and internal medicine residents from included hospitals were surveyed between June and November 2023 (N = 214). We compared five approaches to determining a threshold: decision analysis, maximizing the sensitivity and specificity of a logistic regression model, deriving a probability from a point-based model, surveying physicians\u2019 understanding of VTE risk, and deriving a probability from physician behavior. For each approach, we determined the probability threshold above which a patient would be considered high-risk for VTE. We applied each threshold to the Cleveland Clinic VTE risk assessment model (CCM) and calculated the percentage of the 41,036 patients in our cohort who would be considered eligible for prophylaxis due to their high-risk status. We compared these hypothetical prophylaxis rates with physicians\u2019 observed prophylaxis rates.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The different approaches yielded thresholds ranging from 0.3% to 5.4%, corresponding inversely with hypothetical prophylaxis rates of 0.2% to 75%. Multiple thresholds clustered between 0.52% to 0.55%, suggesting an average hypothetical prophylaxis rate of approximately 30%, whereas physicians\u2019 observed prophylaxis rates ranged from 48% to 76%.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Multiple approaches to determining a probability threshold for VTE prophylaxis converged to suggest an optimal threshold of approximately 0.5%. Other approaches yielded extreme thresholds that are unrealistic for clinical practice. Physicians prescribed prophylaxis much more frequently than the suggested rate of 30%, indicating opportunity to reduce unnecessary prophylaxis. To aid in these efforts, guidelines should explicitly quantify high-risk.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2024.08.30.24312871","type":"posted-content","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T01:05:14Z","timestamp":1725239114000},"source":"Crossref","is-referenced-by-count":1,"title":["What Constitutes High Risk for Venous Thromboembolism? Comparing Approaches to Determining an Appropriate Threshold"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7721-5822","authenticated-orcid":false,"given":"Benjamin G","family":"Mittman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phuc","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0353-1785","authenticated-orcid":false,"given":"Matthew A","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6244-0840","authenticated-orcid":false,"given":"Aaron","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2063-1876","authenticated-orcid":false,"given":"Michael B","family":"Rothberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024090322500829000_2024.08.30.24312871v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2009.12.017"},{"key":"2024090322500829000_2024.08.30.24312871v1.2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20983"},{"key":"2024090322500829000_2024.08.30.24312871v1.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.02196.x"},{"key":"2024090322500829000_2024.08.30.24312871v1.4","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.11.1245"},{"key":"2024090322500829000_2024.08.30.24312871v1.5","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.38733.466748.7C"},{"key":"2024090322500829000_2024.08.30.24312871v1.6","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000138928.83266.24"},{"key":"2024090322500829000_2024.08.30.24312871v1.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909093411103"},{"key":"2024090322500829000_2024.08.30.24312871v1.8","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31828cf104"},{"key":"2024090322500829000_2024.08.30.24312871v1.9","doi-asserted-by":"publisher","DOI":"10.1186\/1752-2897-4-1"},{"key":"2024090322500829000_2024.08.30.24312871v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2023.11.017"},{"key":"2024090322500829000_2024.08.30.24312871v1.11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2301"},{"key":"2024090322500829000_2024.08.30.24312871v1.12","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018022954"},{"key":"2024090322500829000_2024.08.30.24312871v1.13","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000818"},{"key":"2024090322500829000_2024.08.30.24312871v1.14","doi-asserted-by":"crossref","unstructured":"Qaseem A , Chou R , Humphrey LL , Starkey M , Shekelle P . Venous Thromboembolism Prophylaxis in Hospitalized Patients: A Clinical Practice Guideline From the American College of Physicians.; 2011. www.annals.org","DOI":"10.7326\/0003-4819-155-9-201111010-00011"},{"key":"2024090322500829000_2024.08.30.24312871v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.06.004"},{"key":"2024090322500829000_2024.08.30.24312871v1.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.04044.x"},{"key":"2024090322500829000_2024.08.30.24312871v1.17","doi-asserted-by":"publisher","DOI":"10.1007\/S11239-010-0455-7"},{"key":"2024090322500829000_2024.08.30.24312871v1.18","doi-asserted-by":"publisher","DOI":"10.1111\/JTH.13687"},{"key":"2024090322500829000_2024.08.30.24312871v1.19","doi-asserted-by":"publisher","DOI":"10.1055\/A-1698-6506\/ID\/JR210284-2\/BIB"},{"key":"2024090322500829000_2024.08.30.24312871v1.20","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000150640.98772.AF"},{"key":"2024090322500829000_2024.08.30.24312871v1.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909093411103"},{"key":"2024090322500829000_2024.08.30.24312871v1.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02650.x"},{"key":"2024090322500829000_2024.08.30.24312871v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60202-0"},{"key":"2024090322500829000_2024.08.30.24312871v1.24","doi-asserted-by":"publisher","DOI":"10.1378\/chest.106.1.13"},{"key":"2024090322500829000_2024.08.30.24312871v1.25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530040063042"},{"key":"2024090322500829000_2024.08.30.24312871v1.26","doi-asserted-by":"publisher","DOI":"10.1016\/J.RPTH.2023.102184"},{"key":"2024090322500829000_2024.08.30.24312871v1.27","doi-asserted-by":"publisher","DOI":"10.1007\/S11606-020-05993-X\/TABLES\/1"},{"key":"2024090322500829000_2024.08.30.24312871v1.28","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD.V126.23.5563.5563"},{"key":"2024090322500829000_2024.08.30.24312871v1.29","doi-asserted-by":"publisher","DOI":"10.12788\/JHM.2916"},{"key":"2024090322500829000_2024.08.30.24312871v1.30","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e31821a370f"},{"key":"2024090322500829000_2024.08.30.24312871v1.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.zefq.2008.08.013"},{"key":"2024090322500829000_2024.08.30.24312871v1.32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020847"},{"key":"2024090322500829000_2024.08.30.24312871v1.33","doi-asserted-by":"publisher","DOI":"10.1111\/J.1539-6053.2008.00033.X\/ASSET\/IMAGES\/LARGE\/10.1111_J.1539-6053.2008.00033.X-FIG17.JPEG"},{"key":"2024090322500829000_2024.08.30.24312871v1.34","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-5-201203060-00005"},{"key":"2024090322500829000_2024.08.30.24312871v1.35","doi-asserted-by":"publisher","DOI":"10.1007\/S11606-017-4099-6\/TABLES\/3"},{"key":"2024090322500829000_2024.08.30.24312871v1.36","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.12531"},{"key":"2024090322500829000_2024.08.30.24312871v1.37","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21457"},{"key":"2024090322500829000_2024.08.30.24312871v1.38","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001122"},{"key":"2024090322500829000_2024.08.30.24312871v1.39","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.23732"},{"key":"2024090322500829000_2024.08.30.24312871v1.40","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.026693"},{"key":"2024090322500829000_2024.08.30.24312871v1.41","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2020-111521"},{"key":"2024090322500829000_2024.08.30.24312871v1.42","doi-asserted-by":"publisher","DOI":"10.1016\/J.PEC.2015.10.002"},{"key":"2024090322500829000_2024.08.30.24312871v1.43","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-010-1296-y"},{"key":"2024090322500829000_2024.08.30.24312871v1.44","doi-asserted-by":"publisher","DOI":"10.1001\/JAMAINTERNMED.2014.3384"},{"key":"2024090322500829000_2024.08.30.24312871v1.45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-12-758995"},{"key":"2024090322500829000_2024.08.30.24312871v1.46","doi-asserted-by":"publisher","DOI":"10.1016\/J.AMJMED.2016.03.031"},{"key":"2024090322500829000_2024.08.30.24312871v1.47","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3762651"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.08.30.24312871","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:10:46Z","timestamp":1768507846000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2024.08.30.24312871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":47,"URL":"https:\/\/doi.org\/10.1101\/2024.08.30.24312871","relation":{},"subject":[],"published":{"date-parts":[[2024,9,1]]},"subtype":"preprint"}}